The OCEANIC-AF trial has raised concerns about factor XI inhibitors. Should physicians still bet on this class of ...
TAHO Pharmaceuticals announces positive preliminary results from the pivotal study of TAH3311, the world's first Apixaban oral dissolving film (ODF). The study confirmed that TAH3311 is bioequivalent ...
TAIPEI, Feb. 17, 2025 /PRNewswire/ -- TAHO Pharmaceuticals announces positive preliminary results from the pivotal study of TAH3311, the world's first Apixaban ... of deep vein thrombosis or ...
Purpose The pharmacology, pharmacokinetics, efficacy, and safety of apixaban are reviewed ... and has been administered in a twice-daily dosing regimen in clinical trials without the need for ...
TAIPEI, Feb. 17, 2025 /PRNewswire/ -- TAHO Pharmaceuticals announces positive preliminary results from the pivotal study of TAH3311, the world's first Apixaban ... can lead to dosing inaccuracies ...
GlobalData on MSN4d
Taho Pharma’s apixaban oral strips equivalent to Eliquis in pivotal trialTaho Pharmaceuticals’s apixaban-based oral dissolving strips were discovered to be a bioequivalent of Pfizer and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback